Clinical Trials in Manchester, UK

Clinical Trials in Manchester

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Active, closed

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

NCT02908906Neoplasms

Janssen Research & Development, LLC

Phase 1/2

234

Glasgow, London, Manchester, Newcastle upon Tyne

2016-11-21

Active, closed

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer

NCT02609776Non-Small-Cell Lung Cancer

Janssen Research & Development, LLC

Phase 1

751

Manchester, Newcastle upon Tyne, Sutton

2016-05-24

Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma

Janssen Research & Development, LLC

Phase 3

700

Birmingham, Bournemouth, Colchester, Glasgow, Leeds, Leicester, London, Manchester

2013-09-09

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 September 2026. https://priyalifescience.com/clinical-trials-uk/city/manchester

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →